The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
In Vivo Downregulation of T Helper Cell 1 Immune Responses Reduces Atherogenesis in Apolipoprotein E-Knockout Mice
Abstract
Background — A chronic immune response involving proinflammatory T helper cell 1 (Th1) lymphocyte activation occurs in the atherosclerotic lesion, but whether this activation is protective or deleterious remains unclear. Methods and Results — We modulated the immune response of the atherosclerosis-prone apolipoprotein E-deficient (apoE −/− ) mouse. Eight-week-old apoE −/− mice were treated daily with pentoxifylline (PTX), a known inhibitor of the Th1 differentiation pathway, or PBS (control) for 4 weeks or 12 weeks. Twelve-week PTX treatment reduced atherosclerotic lesion size by 60% ( P <0.01). PTX-treated mice developed lesions that were limited to the degree of fatty streaks. In contrast, control mice developed mature fibrofatty atherosclerotic lesions. In parallel, the proportion of interferon (IFN)-γ-producing Th1 splenic lymphocytes was significantly reduced by PTX, and lesion size was correlated to the proportion of IFN-γ + T cells. In vitro addition of PTX to cultured spleen cells did not modify the production of IFN-γ but increased the production of IL-10 by T cells, indicating that PTX does not suppress IFN-γ production but rather blocks Th1 polarization while promoting Th2 polarization. Conclusions — Thus, PTX protected mice from atherosclerosis by reducing the Th1 polarization of T helper lymphocytes. This study demonstrates that the Th1 immune response associated with atherosclerosis is deleterious and that a modulation of the Th1 differentiation pathway may provide a new pharmacological tool to treat this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Ward, A., & Clissold, S. P. (1987) · Drugs · doi:10.2165/00003495-198734010-00003 · Cited by 1,754
Del Prete, G., De Carli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R., & Romagnani, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.2.353 · Cited by 927
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 868
Protective Role of Interleukin-10 in Atherosclerosis
Mallat, Z., Besnard, S., Duriez, M., Deleuze, V., Emmanuel, F., Bureau, M. F., Soubrier, F., Esposito, B., Duez, H., Fievet, C., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.8.e17 · Cited by 831
Detection of activated T lymphocytes in the human atherosclerotic plaque.
Hansson, G. K., Holm, J., & Jonasson, L. (1989) · Europe PMC (PubMed Central) · Cited by 744
Self-citationOpenshaw, P., Murphy, E. E., Hosken, N. A., Maino, V, Davis, K., Murphy, K., & O'Garra, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1357 · Cited by 538
The combined role of P- and E-selectins in atherosclerosis.
Dong, Z. M., Chapman, S. M., Brown, A. A., Frenette, P. S., Hynes, R. O., & Wagner, D. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3001 · Cited by 459
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.
Uyemura, K., Demer, L. L., Castle, S. C., Jullien, D., Berliner, J. A., Gately, M. K., Warrier, R. R., Pham, N., Fogelman, A. M., & Modlin, R. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118650 · Cited by 427
Zhou, X., Paulsson, G., Stemme, S., & Hansson, G. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1216 · Cited by 413
Self-citationInterleukin-10 Blocks Atherosclerotic Events In Vitro and In Vivo
Pinderski Oslund, L. J., Hedrick, C. C., Olvera, T., Hagenbaugh, A., Territo, M., Berliner, J. A., & Fyfe, A. I. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.12.2847 · Cited by 396
A Tale of Two Diseases: Atherosclerosis and Rheumatoid Arthritis
Pasceri, V., & Yeh, E. T. H. (1999) · Circulation · doi:10.1161/01.cir.100.21.2124 · Cited by 377
Increasing cAMP attenuates activation of mitogen-activated protein kinase.
Sevetson, B. R., Kong, X., & Lawrence, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10305 · Cited by 371
The Role of Interleukin 12 in the Development of Atherosclerosis in ApoE-Deficient Mice
Lee, T.-S., Yen, H.-C., Pan, C.-C., & Chau, L.-Y. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.734 · Cited by 311
Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.
Nicoletti, A., Kaveri, S., Caligiuri, G., Bariéty, J., & Hansson, G. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119892 · Cited by 301
Self-citationMultiple effects of tumor necrosis factor on lipoprotein lipase in vivo.
Semb, H., Peterson, J., Tavernier, J., & Olivecrona, T. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47576-x · Cited by 238
Endres, S., Fülle, H., Sinha, B. N. M., Stoll, D., Dinarello, C. A., Gerzer, R., & Weber, P. C. (1991) · PubMed Central · Cited by 238
Pober, J. S., Slowik, M. R., De Luca, L. G., & Ritchie, A. J. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.11.5114 · Cited by 188
Rott, O., Cash, E., & Fleischer, B. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230802 · Cited by 163
Rieckmann, P., Weber, F., Günther, A., Martin, S., Bitsch, A., Broocks, A., Kitze, B., Weber, T., Börner, T., & Poser, S. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00176-x · Cited by 103
Bright, J. J., Du, C., Coon, M. E., Sriram, S., & Klaus, S. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.7015 · Cited by 89
Seo, H. S., Lombardi, D. M., Polinsky, P., Powell-Braxton, L., Bunting, S., Schwartz, S. M., & Rosenfeld, M. E. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.12.3593 · Cited by 89
Inhibition of human interleukin‐12 production by pentoxifylline
Möller, D. R., Wysocka, M., Greenlee, B. M., Ma, X., Wahl, L. M., Trinchieri, G., & Karp, C. L. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00246.x · Cited by 84
The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
Liang, L., Beshay, E., & Prud’homme, G. J. (1998) · Diabetes · doi:10.2337/diabetes.47.4.570 · Cited by 69
IMMUNOMODULATORY EFFECT OF PENTOXIFYLLINE DURING HUMAN ALLOGRAFT REJECTION
Noël, C., Copin, M., Hazzan, M., Labalette, M., Susen, S., Lelievre, G., & Dessaint, J. (2000) · Transplantation · doi:10.1097/00007890-200003270-00014 · Cited by 31
Cited by
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Self-citationThe immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182
Self-citationCytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Macrophage death and defective inflammation resolution in atherosclerosis
Tabas, I. (2010) · Nature Reviews Immunology · doi:10.1038/nri2675 · Cited by 1,120
INFLAMMATION AND ATHEROSCLEROSIS
Hansson, G. K., Robertson, A.-K. L., & Söderberg-Nauclér, C. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100100 · Cited by 1,046
Self-citation
Metadata
- Authors
- Laurat, E., Poirier, B., Tupin, E., Caligiuri, G., Hansson, G. K., Bariéty, J., & Nicoletti, A.
- Venue
- Circulation
- Published
- 2001-07-10
- Volume
- 104
- Issue
- 2
- Pages
- 197-202
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1999742425
- Cited by
- 286
- References
- 25
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.